Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE)
CUSIP: 22978P106
Q2 2018 13F Holders as of 30 Jun 2018
- Type / Class
- Equity / Common Stock, $0.001 par value per share
- Shares outstanding
- 43,411,663
- Total 13F shares
- 3,148,586
- Share change
- +1,305,231
- Total reported value
- $37,344,175
- Price per share
- $11.86
- Number of holders
- 37
- Value change
- +$15,445,827
- Number of buys
- 30
- Number of sells
- 5
Quarterly Holders Quick Answers
What is CUSIP 22978P106?
CUSIP 22978P106 identifies CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 22978P106:
Top shareholders of CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| First Eagle Investment Management, LLC |
13F
|
Company |
1.2%
|
500,000
|
$7,025,000 | — | 31 Mar 2018 | |
| VANGUARD GROUP INC |
13F
|
Company |
1%
|
451,863
|
$6,349,000 | — | 31 Mar 2018 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.91%
|
394,827
|
$5,547,000 | — | 31 Mar 2018 | |
| STATE STREET CORP |
13F
|
Company |
0.27%
|
118,010
|
$1,658,000 | — | 31 Mar 2018 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.17%
|
75,153
|
$1,056,000 | — | 31 Mar 2018 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.16%
|
71,234
|
$1,000,000 | — | 31 Mar 2018 | |
| CITIGROUP INC |
13F
|
Company |
0.13%
|
56,064
|
$788,000 | — | 31 Mar 2018 | |
| P.A.W. CAPITAL CORP |
13F
|
Company |
0.07%
|
30,000
|
$422,000 | — | 31 Mar 2018 | |
| MORGAN STANLEY |
13F
|
Company |
0.05%
|
23,307
|
$327,000 | — | 31 Mar 2018 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.05%
|
22,275
|
$313,000 | — | 31 Mar 2018 | |
| Virtu Financial LLC |
13F
|
Company |
0.04%
|
16,544
|
$232,000 | — | 31 Mar 2018 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.04%
|
16,300
|
$230,000 | — | 31 Mar 2018 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.03%
|
13,573
|
$191,000 | — | 31 Mar 2018 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.03%
|
11,429
|
$159,000 | — | 31 Mar 2018 | |
| TEACHERS ADVISORS, LLC |
13F
|
Company |
0.02%
|
10,597
|
$149,000 | — | 31 Mar 2018 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.02%
|
7,669
|
$107,000 | — | 31 Mar 2018 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0.01%
|
5,697
|
$80,000 | — | 31 Mar 2018 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.01%
|
5,094
|
$72,000 | — | 31 Mar 2018 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
3,695
|
$52,000 | — | 31 Mar 2018 | |
| STRS OHIO |
13F
|
Company |
0.01%
|
2,500
|
$35,000 | — | 31 Mar 2018 | |
| BARCLAYS PLC |
13F
|
Company |
0%
|
1,843
|
$26,000 | — | 31 Mar 2018 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
1,795
|
$25,000 | — | 31 Mar 2018 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
1,737
|
$24,405 | — | 31 Mar 2018 | |
| Legal & General Group Plc |
13F
|
Company |
0%
|
1,559
|
$22,000 | — | 31 Mar 2018 | |
| Ameritas Investment Partners, Inc. |
13F
|
Company |
0%
|
752
|
$11,000 | — | 31 Mar 2018 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
660
|
$9,000 | — | 31 Mar 2018 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
413
|
$6,000 | — | 31 Mar 2018 | |
| LADENBURG THALMANN FINANCIAL SERVICES INC. |
13F
|
Company |
0%
|
120
|
$2,000 | — | 31 Mar 2018 | |
| PNC FINANCIAL SERVICES GROUP, INC. |
13F
|
Company |
0%
|
92
|
$2,000 | — | 31 Mar 2018 |
Institutional Holders of Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) as of Q2 2018
As of 30 Jun 2018,
Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) was held by
37 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,148,586 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, Nantahala Capital Management, LLC, STATE STREET CORP, First Eagle Investment Management, LLC, NORTHERN TRUST CORP, GEODE CAPITAL MANAGEMENT, LLC, Bank of New York Mellon Corp, MORGAN STANLEY, and TIAA CREF INVESTMENT MANAGEMENT LLC.
This page lists
37
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2018 vs Q1 2018 Across Filers
Q1 2018 holders
28
Q2 2018 holders
37
Holder diff
9
| Investor | Q1 2018 Shares | Q2 2018 Shares | Share Diff | Share Chg % | Q1 2018 Value $ | Q2 2018 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.